260 related articles for article (PubMed ID: 29603404)
1. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
Brück J; Dringen R; Amasuno A; Pau-Charles I; Ghoreschi K
Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
[TBL] [Abstract][Full Text] [Related]
2. The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects.
Mrowietz U; Morrison PJ; Suhrkamp I; Kumanova M; Clement B
Trends Pharmacol Sci; 2018 Jan; 39(1):1-12. PubMed ID: 29183628
[TBL] [Abstract][Full Text] [Related]
3. Fumaric acid esters.
Rostami Yazdi M; Mrowietz U
Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
[TBL] [Abstract][Full Text] [Related]
4. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
5. Dimethylfumarate for psoriasis: more than a dietary curiosity.
Mrowietz U; Asadullah K
Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
Litjens NH; van Strijen E; van Gulpen C; Mattie H; van Dissel JT; Thio HB; Nibbering PH
BMC Pharmacol; 2004 Oct; 4():22. PubMed ID: 15479475
[TBL] [Abstract][Full Text] [Related]
7. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
Tahvili S; Zandieh B; Amirghofran Z
Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells.
Eminel S; Jin N; Rostami M; Dibbert S; Mrowietz U; Suhrkamp I
Exp Dermatol; 2017 Aug; 26(8):685-690. PubMed ID: 27376248
[TBL] [Abstract][Full Text] [Related]
9. Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells.
Lee YJ; Bae JH; Kang SG; Cho SW; Chun DI; Nam SM; Kim CH; Nam HS; Lee SH; Lee SH; Cho MK
Arch Pharm Res; 2017 Sep; 40(9):1105-1116. PubMed ID: 28918452
[TBL] [Abstract][Full Text] [Related]
10. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
11. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M
Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203
[TBL] [Abstract][Full Text] [Related]
12. Intracellular signalling by binding sites for the antipsoriatic agent monomethylfumarate on human granulocytes.
Nibbering PH; Thio B; Bezemer AC; Beijersbergen RL; Zomerdijk TP
Br J Dermatol; 1997 Jul; 137(1):65-75. PubMed ID: 9274627
[TBL] [Abstract][Full Text] [Related]
13. Dimethylfumarate induces apoptosis in human mast cells.
Förster A; Preussner LM; Seeger JM; Rabenhorst A; Kashkar H; Mrowietz U; Hartmann K
Exp Dermatol; 2013 Nov; 22(11):719-24. PubMed ID: 24112621
[TBL] [Abstract][Full Text] [Related]
14. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells.
Stoof TJ; Flier J; Sampat S; Nieboer C; Tensen CP; Boorsma DM
Br J Dermatol; 2001 Jun; 144(6):1114-20. PubMed ID: 11422029
[TBL] [Abstract][Full Text] [Related]
15. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
Gerdes S; Shakery K; Mrowietz U
Br J Dermatol; 2007 May; 156(5):838-42. PubMed ID: 17381463
[TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Lin-Holderer J; Li L; Gruneberg D; Marti HH; Kunze R
Neuropharmacology; 2016 Jun; 105():228-240. PubMed ID: 26801077
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner.
Hoffmann JHO; Schaekel K; Hartl D; Enk AH; Hadaschik EN
Br J Dermatol; 2018 Jan; 178(1):207-214. PubMed ID: 28733990
[TBL] [Abstract][Full Text] [Related]
18. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
[TBL] [Abstract][Full Text] [Related]
19. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Loewe R; Pillinger M; de Martin R; Mrowietz U; Gröger M; Holnthoner W; Wolff K; Wiegrebe W; Jirovsky D; Petzelbauer P
J Invest Dermatol; 2001 Dec; 117(6):1363-8. PubMed ID: 11886496
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
